Zinc Nicotinate

Zinc nicotinate is a chelated compound combining zinc, an essential trace mineral, with nicotinic acid (vitamin B3), theoretically designed to enhance bioavailability of both components. It functions by delivering zinc ions for enzymatic cofactor roles and nicotinic acid for NAD+ precursor activity, though its specific efficacy over other zinc forms remains clinically unverified.

Origin & History

Zinc nicotinate is a mineral complex composed of zinc coordinated with two molecules of nicotinic acid (niacin, vitamin B3), with the molecular formula C₁₂H₈N₂O₄Zn and a molecular weight of 309.6 g/mol. It is synthesized as a salt form combining the essential mineral zinc with the B-vitamin nicotinic acid, creating a bioavailable mineral powder formulation.

Historical & Cultural Context

The research dossier does not contain historical information about zinc nicotinate's use in traditional medicine systems. No traditional or cultural usage data was provided in the available sources.

Health Benefits

• Limited clinical evidence available - no specific health benefits documented in the provided research
• Theoretical zinc supplementation benefits not verified for this specific form
• Theoretical nicotinic acid benefits not verified for this specific form
• No human clinical trials found in the research dossier
• Further research needed to establish evidence-based health claims

How It Works

Zinc nicotinate theoretically dissociates in the gastrointestinal tract to release zinc ions and nicotinic acid, with zinc acting as a cofactor for over 300 metalloenzymes including carbonic anhydrase, matrix metalloproteinases, and DNA polymerase. Nicotinic acid serves as a precursor to NAD+ and NADP+, coenzymes critical for redox reactions and cellular energy metabolism via the Krebs cycle. The chelation with nicotinic acid is hypothesized to improve intestinal mucosal absorption compared to inorganic zinc salts by reducing competition with other divalent cations at DMT1 transporters, though this has not been confirmed in controlled human trials.

Scientific Research

The provided research dossier does not contain specific human clinical trials, randomized controlled trials (RCTs), or meta-analyses examining zinc nicotinate as a standalone intervention. The available sources focus on the chemical characterization and general properties of the compound rather than clinical efficacy data.

Clinical Summary

No published human clinical trials have specifically investigated zinc nicotinate as an isolated intervention, making it impossible to quantify efficacy or compare it directly to well-studied forms such as zinc gluconate or zinc acetate. General zinc supplementation research demonstrates benefits for immune function, wound healing, and testosterone maintenance at doses of 25–45 mg elemental zinc daily, but these findings cannot be extrapolated to zinc nicotinate without form-specific data. Nicotinic acid at pharmacological doses (1–3 g/day) has established lipid-modifying effects in separate trials, but the nicotinic acid content delivered by typical zinc nicotinate supplement doses is far too low to replicate these outcomes. The overall evidence base for zinc nicotinate specifically is classified as insufficient, and consumers should treat any health claims for this particular form with caution.

Nutritional Profile

Zinc Nicotinate is a zinc salt of nicotinic acid (niacin/vitamin B3), functioning as a dual-mineral-vitamin compound. Molecular formula: Zn(C6H4NO2)2, molecular weight approximately 261.53 g/mol. Zinc content: approximately 25% elemental zinc by molecular weight (~25mg zinc per 100mg compound). Nicotinic acid content: approximately 75% by molecular weight, providing two nicotinate ligands per zinc ion. As a mineral chelate, zinc is coordinate-bonded to the carboxylate groups of nicotinic acid, theoretically enhancing gastrointestinal absorption compared to inorganic zinc salts (zinc oxide, zinc sulfate) by facilitating transport via amino acid/organic acid absorption pathways. Elemental zinc contribution: a typical 15-30mg elemental zinc equivalent dose would require approximately 60-120mg of zinc nicotinate. The nicotinate moiety may contribute measurable niacin equivalents upon dissociation in the gut, though the extent of metabolic splitting is not well-quantified in published literature. No fiber, protein, or fat content. Trace moisture may be present in powder form. Bioavailability: chelated zinc forms generally demonstrate 20-40% improved absorption versus zinc oxide; zinc nicotinate-specific bioavailability studies in humans remain unpublished in the peer-reviewed literature as of current knowledge.

Preparation & Dosage

No clinically studied dosage ranges, standardization protocols, or dosing recommendations for zinc nicotinate were found in the provided research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient research data to recommend synergistic combinations

Safety & Interactions

Zinc supplementation in general is considered safe at doses up to the Tolerable Upper Intake Level of 40 mg elemental zinc per day for adults, with nausea, vomiting, and gastrointestinal distress reported at higher doses; chronic excess zinc above 50 mg/day can competitively inhibit copper absorption, potentially causing hypocupremia and neurological deficits. Nicotinic acid at high doses is associated with flushing, hepatotoxicity, and hyperglycemia, but the nicotinic acid load from typical zinc nicotinate formulations is unlikely to reach these thresholds. Zinc can reduce the absorption of fluoroquinolone and tetracycline antibiotics when co-administered, and may interact with penicillamine and thiazide diuretics by altering zinc excretion. Pregnant and breastfeeding individuals should not exceed the recommended dietary allowance for zinc (11 mg and 12 mg/day respectively) without medical supervision, and zinc nicotinate lacks any pregnancy-specific safety data.